The Society for Cardiovascular Angiography & Interventions (SCAI) and Cardiovascular Research Technologies (CRT) today announce a new collaboration to elevate the field of interventional cardiology through shared education programming, legislative activities, and future research initiatives.<\/p>\n
As part of the collaboration,\u00a0CRT is offering SCAI members discounted registration for CRT 2026,\u00a0where the two\u00a0organizations will\u00a0also\u00a0offer joint education. Supporting\u00a0SCAI and\u00a0CRT’s strong advocacy focus, SCAI will coordinate an annual\u00a0Day on the Hill legislative event\u00a0tied to the CRT\u00a0meeting in Washington, DC.\u00a0Over the long term,\u00a0SCAI and CRT will explore collaborative research opportunities, including\u00a0novel\u00a0registry and\u00a0clinical trial\u00a0programs.\u00a0<\/p>\n
“Collaboration is key to the future of medicine-interventional cardiology in particular-and SCAI’s commitment to improve outcomes for our patients. SCAI and CRT share a common mission to advance interventional cardiology through collaboration, science, advocacy, regulatory policies, and education. While coming at these goals from different vantage points, our new partnership reflects the growing alignment in vision, and SCAI looks forward to the many benefits of working together with CRT,” said Srihari S. Naidu, MD, MSCAI, president of SCAI.<\/p>\n
The partnership will be guided by the SCAI\u2013CRT Task Force, composed of representatives from both organizations who will identify and coordinate collaborative opportunities. In support of these initiatives, SCAI will form a working group to evaluate research projects, including the development of registries and clinical trials, to be submitted by SCAI, its members, and CRT’s research network. CRT will provide core lab services, and SCAI and CRT will work jointly to secure external funding.<\/p>\n
“Together, we will create new avenues to engage physicians, foster innovation, and build programs that address the clinical and policy challenges shaping our field. By combining our strengths, we can accelerate investigator-led research, expand professional development, and ultimately deliver better care for patients,” said J. Dawn Abbott, MD, MSCAI, chair of the SCAI\u2013CRT Partnership Task Force and president-elect of SCAI.<\/p>\n
“Through CRT’s collaboration with SCAI, we’re expanding the impact of both organizations. This partnership allows us to connect clinical science, advocacy, and education in ways that will drive innovation and bring together experts from across cardiovascular medicine. Our shared vision is to strengthen the pipeline of research, inspire the next generation of interventionalists, and ensure that patients everywhere benefit from the rapid progress being made in the interventional lab,” said Ron Waksman, MD, MSCAI, chair of the CRT meeting.<\/p>\n
Source:<\/p>\n